Appeal from a judgment of the United States District Court for the Southern District of New York (Cathy Seibel, Judge).
Dykstra v. Wyeth Pharmaceuticals, Inc.
Rulings by summary order do not have precedential effect. Citation to a summary order filed on or after January 1, 2007, is permitted and is governed by Federal Rule of Appellate Procedure 32.1 and this Court's Local Rule 32.1.1. When citing a summary order in a document filed with this Court, a party must cite either the Federal Appendix or an electronic database (with the notation "summary order"). A party citing a summary order must serve a copy of it on any party not represented by counsel.
1 At a stated term of the United States Court of Appeals for the Second Circuit, held at the Daniel 2 Patrick Moynihan United States Courthouse, 500 Pearl Street, in the City of New York, on the 4th day 3 of January, two thousand twelve.
PRESENT: JOSEPH M. MCLAUGHLIN, JOSE A. CABRANES, DEBRA ANN LIVINGSTON, Circuit Judges.
UPON DUE CONSIDERATION, IT IS HEREBY ORDERED, ADJUDGED, 9 AND DECREED that the judgment of the District Court is AFFIRMED.
10 Plaintiff-appellant Joseph Dykstra ("Dykstra") appeals from a judgment entered September 11 16, 2010, granting the motion for summary judgment of defendant-appellee Wyeth Pharmaceuticals 12 ("Wyeth"). The District Court granted Wyeth's motion solely on the basis that the applicable 13 statute of limitations had expired before Dykstra filed his complaint. We assume the parties' 14 familiarity with the underlying facts, procedural history of the case, and the issues on appeal.
15 Dykstra was employed by Wyeth as an aseptic setup worker, with responsibilities including 16 setting up and maintaining equipment used to fill biological syringes. As a union employee, his 17 employment was governed by the terms of a Collective Bargaining Agreement ("CBA") between 18 Wyeth and the International Chemical Workers Union, Local 143c. Pursuant to the CBA, "[a]n 19 employee whose action appears to necessitate his/her discharge shall first be suspended subject to 20 discharge and so be informed. If no request for grievance procedure is made within seven (7) days, 21 the action taken by the Company shall become final."
22 On or about March 29, 2007, Wyeth learned that Dykstra had signed the initials of other 23 employees on documents that Wyeth maintained as part of its obligation, as a manufacturer 24 regulated by the Food and Drug Administration ("FDA"), to document its compliance with FDA 1 requirements for good manufacturing practices. Section IV of the Wyeth Manufacturing Employee 2 Manual provides that "[i]ntentional falsification of a cGMP document [that is, a document that 3 confirms compliance with FDA good manufacturing practices] by any employee will result in 4 immediate suspension pending discharge!" On April 17, 2007, Dykstra's supervisor issued him a 5 notice of suspension pending discharge for falsifying cGMP documents. He was immediately 6 escorted from the facility and relieved of his facility entrance card and employee badge. Dykstra's 7 pay was halted the same day.
8 Within the seven days allotted by the CBA, Dykstra, through his union, filed a grievance. 9 A hearing was held on May 22, 2007 before the Associate Director of Labor Relations. By letter 10 of June 11, 2007, the Associate Director advised Dykstra that he had been found responsible for 11 falsifying cGMP documents and therefore his employment was terminated effective June 11, 2007.
12 On June 6, 2008, Dykstra filed a complaint in the Supreme Court of the State of New York, 13 Rockland County, alleging that he was terminated in retaliation for reporting safety violations to a 14 supervisor.*fn1 This termination, he claimed, violated the New York "whistle-blower statute," N.Y. 15 Labor Law § 740, which prohibits an employer from taking "any retaliatory personnel action against 16 an employee" because the employee discloses to a supervisor or public body an activity, policy or 17 practice of the employer that violates a "law, rule or regulation which violation creates and presents 18 a substantial and specific danger to the public health or safety, or which constitutes health care 19 fraud." N.Y. Lab. Law § 740(2)(a). Dykstra alleged that he was discharged in retaliation for 20 reporting to a supervisor in March 2007 that he had observed two maintenance workers in a "clean 1 room" failing to comply with sterilization procedures and lacking proper certification, in violation 2 of Wyeth policies.*fn2
3 Section 740 permits an employee who believes he has been retaliated against in violation of 4 the statute to "institute a civil action . . . within one year after the alleged retaliatory personnel action 5 was taken." Id. The dispositive question before the District Court, therefore, was whether 6 Dykstra's cause of action accrued on April 17, 2007, when he was notified of his suspension 7 pending discharge, or June 11, 2007, the effective date of his termination. The District Court 8 concluded that his cause of action accrued on April 17, 2007, and that his complaint, filed June 6, 9 2008, was thus barred by the one-year statute of limitations. It accordingly granted Wyeth's motion 10 for summary judgment.
11 "We review de novo the district court's grant of summary judgment, drawing all factual 12 inferences in favor of the non-moving party." Paneccasio v. Unisource Worldwide, Inc., 532 F.3d 101, 13 107 (2d Cir. 2008). "Summary judgment is proper only when, construing the evidence in the light 14 most favorable to the non-movant, 'there is no genuine dispute as to any material fact and the 15 movant is entitled to judgment as a matter of law.'" Doninger v. Niehoff, 642 F.3d 334, 344 (2d Cir. 16 2011) (quoting Fed. R. Civ. P. 56(a)). Having conducted a de novo review of the record and 17 considered the parties' submissions, we agree with the ...